TTRX — Turn Therapeutics Inc. Common Stock
NASDAQ · Healthcare · Biotechnology
$9.54
-$0.28 (-2.80%)
Turn Therapeutics Inc. Common Stock (TTRX) is a biotechnology company listed on NASDAQ. It is led by Bradley E. Burnam, based in 250 N Westlake Blvd, Westlake Village, CA, United States, 91362, with about 2 employees. Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. The company was formerly known as Global Health Solutions, Inc and change its name to Turn Therapeutics Inc. in September 2025. Turn Therapeutics Inc. was incorporated in 2015 and is based in Westlake Village, California.
Net income was -$1.9M. TTRX currently screens at market cap $187.1M.
Use this TTRX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the TTRX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the TTRX SEC filings page. Lician reads the product cache first so this HTML stays unique to Turn Therapeutics Inc. Common Stock even when a live quote feed is slow.
About Turn Therapeutics Inc. Common Stock
Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. The company was formerly known as Global Health Solutions, Inc and change its name to Turn Therapeutics Inc. in September 2025. Turn Therapeutics Inc. was incorporated in 2015 and is based in Westlake Village, California.
TTRX Key Statistics
Market Cap
$187.07M
Volume
31,385
Previous Close
$9.68
Day Range
$9.58 – $10.04
P/B Ratio
31.26
EPS
-$0.07
Revenue
$0.00
Net Income
-$1.90M
Gross Profit
$0.00
Free Cash Flow
$0.00
Employees
2
TTRX Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 |
| Net Income | -$1.90M | -$666.44K |
| EPS (Diluted) | -$0.07 | -$0.03 |
Total Assets
$4.30M
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$513.70K
Operating Cash Flow
-$1.39M
Free Cash Flow
$0.00
Turn Therapeutics Inc. Common Stock Company Information
- Founder, CEO & Director
- Bradley E. Burnam
- Headquarters
- 250 N Westlake Blvd, Westlake Village, CA, United States, 91362
- Website
- turntherapeutics.com
- Phone
- 818 546 4011
- IPO / Founded
- 2025-10-08
- Sector
- Healthcare
- Industry
- Biotechnology